Cargando…
Evidence of shared transcriptomic dysregulation of HNRNPU-related disorder between human organoids and embryonic mice
Generating effective therapies for neurodevelopmental disorders has remained elusive. An emerging drug discovery approach for neurodevelopmental disorders is to characterize transcriptome-wide dysregulation in an appropriate model system and screen therapeutics based on their capacity to restore fun...
Autores principales: | Ressler, Andrew K., Sampaio, Gabriela L.A., Dugger, Sarah A., Sapir, Tamar, Krizay, Daniel, Boland, Michael J., Reiner, Orly, Goldstein, David B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804147/ https://www.ncbi.nlm.nih.gov/pubmed/36594023 http://dx.doi.org/10.1016/j.isci.2022.105797 |
Ejemplares similares
-
Neurodevelopmental deficits and cell-type-specific transcriptomic perturbations in a mouse model of HNRNPU haploinsufficiency
por: Dugger, Sarah A., et al.
Publicado: (2023) -
Heterogeneous nuclear ribonucleoprotein U (HNRNPU) safeguards the developing mouse cortex
por: Sapir, Tamar, et al.
Publicado: (2022) -
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
por: Shi, Zhen-duo, et al.
Publicado: (2022) -
Germline pathogenic variants in HNRNPU are associated with alterations in blood methylome
por: Lee, Sunwoo, et al.
Publicado: (2023) -
Gene trapping: An antibody-dependent approach for verifying integration in your favorite gene
por: Gorelik, Anna, et al.
Publicado: (2008)